An new class of modified nucleosides, 6-hetaryl-7-deazapurine ribonucleosides that exert cytostatic activity against a brad spectrum of cancer and leukemia cell lines at nanomolar concentrations, has been discovered.
An new class of modified nucleosides, 6-hetaryl-7-deazapurine ribonucleosides that exert cytostatic activity against a brad spectrum of cancer and leukemia cell lines at nanomolar concentrations, has been discovered. (en)